| Title | Date | PubMed ID |
|---|
| Structure-based drug design of diphenyl α-aminoalkylphosphonates as prostate-specific antigen antagonists. | 2014 Oct 27 | 25186464 |
| Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activity. | 2014 | 25237904 |
| Prostate specific membrane antigen produces pro-angiogenic laminin peptides downstream of matrix metalloprotease-2. | 2013 Oct | 23775497 |
| Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors. | 2013 Jun 13 | 23692593 |
| PSA forms complexes with α1-antichymotrypsin in prostate. | 2013 Jan | 22806587 |
| A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. | 2011 May | 21419439 |
| Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. | 2011 Feb | 21167529 |
| Galectin-3 is a substrate for prostate specific antigen (PSA) in human seminal plasma. | 2011 Feb 1 | 20672323 |
| Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen. | 2011 Jan 14 | 21056970 |
| Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues. | 2011 Jan 1 | 21141837 |